Table 1: Reported cases of infective endocarditis due to Streptococcus gordonii. |
||||||||||||||||
Author |
Country |
Pt. no. |
Year |
Age/gender |
Symptoms (time) |
Valve |
Embolism |
Diagnostic modality |
Vegetation (valve/number/size) |
Aneurysm (valve) |
Perforation (valve) |
AR |
MR |
Antibiotic treatment (duration) |
Surgery |
Outcome |
Tomsic et al.6 |
United States |
1 |
2016 |
48/M |
Fever, fatigue, cough (2 months) |
Bicuspid AV, MV |
Yes |
TTE, TEE |
AV/1/< 10 mm, MV/NR/NR |
Yes (NCC AV, anterior MVL) |
Yes (anterior MVL) |
Severe |
Severe |
IV penicilin (6 wk), IV gentamicin (2 wk) |
AVR, MVR |
Cure |
Baca et al.7 |
Peru |
2 |
2017 |
58/M |
Fever, vomiting, low back pain (2 months) |
AV, MV |
Yes |
TEE |
AV/multiples/9 mm, MV/NR/NR |
Yes (anterior MVL) |
Yes (NCC AV) |
Severe |
Severe |
NR |
AVR, MVR |
NR |
Dadon et al.14 |
Israel |
3 |
1998 |
23/F |
Fever (NR) |
MV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV gentamicin (2 wk) |
None |
Cure |
4 |
2006 |
37/M |
Dyspnea (NR) |
AV |
NR |
TTE |
NR |
NR |
NR |
NR |
NR |
NR |
AVR |
Died |
||
5 |
2006 |
45/M |
Fever (NR) |
MV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (6 wk), gentamicin (1 wk) |
MVR |
Cure |
||
6 |
2007 |
75/M |
Fever (NR) |
MV, AV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (6 wk) |
No |
Cure |
||
7 |
2013 |
83/F |
Fever (NR) |
MV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV ceftriaxone (6 wk) |
No |
Cure |
||
8 |
2014 |
78/M |
Fever (NR) |
MV, AV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (6 wk) |
AVR, MVR |
Cure |
||
9 |
2014 |
71/M |
Fever (NR) |
NR |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (6 wk) |
No |
Cure |
||
10 |
2015 |
31/M |
Fever (NR) |
MV |
NR |
TTE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (4 wk) |
MVR |
Cure |
||
11 |
2016 |
82/M |
Low back pain (2 wk) |
MV |
Yes |
TEE |
MV/1/14 mm |
None |
None |
None |
None |
IV penicilin (8 wk) |
None |
Cure |
||
12 |
2016 |
63/M |
Fever, low back pain (2 wk) |
AV |
Yes |
TEE |
AV/1/13 mm |
None |
None |
None |
None |
IV penicilin (8 wk), IV gentamicin (2 wk), oral amoxycyline (4 wk) |
None |
Cure |
||
13 |
2017 |
71/M |
General deterioration (NR) |
AV |
NR |
TEE |
NR |
NR |
NR |
NR |
NR |
IV penicilin (6 wk) |
AVR, MVR |
Cure |
||
Callejo-Goena et al.15 |
Spain |
14 |
2018 |
60/M |
Fever (2 wk) |
MV |
Yes |
TEE |
MV/1/NR |
None |
None |
None |
Severe |
Ceftriaxone (3 months) |
None |
Cure |
Mosailova et al.1 |
United States |
15 |
2019 |
31/M |
Bilateral lower extremity edema (2 days) |
MV |
Yes |
TTE |
MV/1/NR |
None |
None |
None |
Severe |
IV ceftriaxone (6 wk) |
MVR |
NR |
Komorovsky et al.16 |
Ukraine |
16 |
2019 |
11/F |
Fever, weakness, joint pain (NR) |
MV |
None |
NR |
MV/1/6 mm |
None |
None |
None |
Moderate |
NR |
MV annuloplasty |
Cure |
Peechakara et al.17 |
India |
17 |
2019 |
42/M |
Fever, back pain, hemoptysis, joint pain (3 months) |
AV, MV |
None |
TTE, TEE |
AV/NR/NR |
None |
Yes (anterior MVL) |
Moderate |
NR |
IV ceftriaxone (6 wk), IV gentamicin (2 wk) |
None |
NR |
Quan Li et al.18 |
China |
18 |
2020 |
36/M |
Fever (2 months) |
Bicuspid AV |
None |
TTE, TEE |
AV/ NR/NR |
None |
None |
Severe |
NR |
NR |
AVR |
Cure |
Yue Wang et al.19 |
China |
19 |
2020 |
39/F |
Fever, headache (6 months) |
MV |
Yes |
TEE |
MV/multiples/NR |
None |
None |
None |
None |
IV vancomycin (12 days) |
None |
Died |
Bridwell et al.20 |
United States |
20 |
2020 |
63/M |
Fever (3 wk) |
MV |
None |
TEE |
MV/NR/NR |
None |
None |
None |
NR |
IV gentamicin (2 wk), IV penicilin (4 wk) |
None |
Cure |
Arbune et al.21 |
Romania |
21 |
2021 |
23/F |
Fever, malaise (9 wk) |
AV |
None |
TTE |
AV/1/5 mm |
None |
None |
NR |
NR |
IV ceftriaxone (6 wk) |
None |
Cure |
Jiménez Melo et al.22 |
Spain |
22 |
2021 |
76/F |
Dyspnea (4 months) |
Mechanical MV and AV |
Yes |
TEE, FDG-PET / CT |
MV/2/7 mm, AV/1/NR |
None |
None |
None |
None |
IV ceftriaxone (NR) |
None |
NR |
Chang et al.4 |
Malaysia |
23 |
2021 |
28/M |
Fever (1 wk), abdominal pain (3 days) |
Bicuspid AV, MV |
Yes |
TTE |
AV/2/11 × 6 mm, 16 × 8 mm, MV/1/5 × 8 mm |
None |
None |
Severe |
Moderate |
IV penicilin (6 wk) |
NR |
NR |
Lim et al.23 |
Malaysia |
24 |
2022 |
40/M |
Fever (1 month) |
PV |
Yes |
TTE, CT |
PV/1/23 × 12 mm |
None |
None |
None |
None |
IV penicilin (6 wk) |
PVR |
Cure |
Chawla et al.24 |
United States |
25 |
2023 |
27/F |
Sudden loss of vision, Severe headache (4 days) |
MV |
Yes |
TEE |
MV/NR/NR |
None |
None |
None |
NR |
IV ceftriaxone (6 wk) |
None |
Cure |
Qu Yi-Fan et al.25 |
China |
26 |
2023 |
61/M |
Fever, malaise (4 wk) |
Bicuspid AV |
Yes |
TEE |
None |
None |
Yes (AV) |
Moderate-severe |
Mild |
NR |
AVR, AV valvuloplasty |
Cure |
Alanís-Naranjo et al. (present case) |
Mexico |
27 |
2023 |
60/M |
Fever, weight loss (3 wk) |
AV, MV |
None |
TEE |
MV/1/11 × 5 mm |
Yes (anterior MVL) |
Yes (NCC AV, anterior MVL) |
Severe |
Moderate |
IV ceftriaxone (1 month) |
AVR, MVR |
Died |
AR = aortic regurgitation. AV = aortic valve. AVR = aortic valve replacement. CT = computed tomography. F = female. FDG-PET/CT = F-fluorodeoxyglucose positron emission tomography/computed tomography. IV = intravenous. M = male. MR = mitral regurgitation. MV = mitral valve. MVL = mitral valve leaflet. MVR = mitral valve replacement. NCC = noncoronary cusp. NR = not reported. Pt = patient. PV = pulmonary valve. PVR = pulmonary valve replacement. TEE = trans-esophageal echocardiogram. TTE = trans-thoracic echocardiogram. |